Trial Profile
Optimal Dose of Ticagrelor 90 mg qd and Double Standard-dose Clopidogrel on Platelet Aggregation in Clopidogrel Resistance's Patients With Coronary Heart Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
- Indications Coronary disorders
- Focus Therapeutic Use
- 10 Aug 2018 New trial record